openPR Logo
Press release

Favivir by Hetero Healthcare for Mild to Moderate Covid-19 is Available Now

07-30-2020 11:26 AM CET | Health & Medicine

Press release from: Hetero Healthcare Limited

Favivir by Hetero Healthcare for Mild to Moderate Covid-19

About FAVIVIR
FAVIVIR is the brand name of the generic Favipiravir (200 mg) drug which acts against different forms of influenza viruses including those that do not work on other medications. Favipiravir is a novel antiviral drug, which selectively and effectively inhibits influenza RNA-dependent polymerase (RdRP) and many other RNA viruses. FAVIVIR increases adherence to care for a large portion of the Covid-19 patient population, which typically has mild to moderate symptoms. The medication must not be used in mothers who are pregnant or who are breastfeeding.
Favipiravir showed effectiveness in clinical trials above 80% and demonstrated safety without any new or previously unreported side effects. The medication has demonstrated positive clinical outcomes.
Dose and Route of Administration
FAVIVIR is in the form of tablets that are given orally. The dosage is 1800 mg (9 tablets) twice daily (total 18 tablets) on day 1 followed by 800 mg (4 tablets) twice daily (total 8 tablets per day) from day 2 up to a maximum of 14 days.
Price of FAVIVIR
FAVIVIR is priced at INR 59 a tablet and is available at all retail medical outlets and hospital pharmacies across the country from July 29, 2020, onwards. This drug is to be sold only with a prescription from a registered medical practitioner.
More About the Drug
If you want to know more details about the drug or if you have any query related to FAVIVIR, you can always reach out to us by dialing our Toll-free Number 18001034696. You can even email us at lead@heterohealthcare.com. Hetero Healthcare addresses every query and in case a call is missed, we have planned in such a way that an outbound call happens and the patient’s issue is addressed. Hetero Healthcare has always been a patient-centric organization and during these times of pandemic, we have always tried to give our best.
For Enquiries
~Visit http://www.heterohealthcare.com/favipiravir-tablets

Hetero Healthcare Limited
S.no: 80-84, Melange Towers, Patrika Nagar, Madhapur, Hyderabad, Telangana 500081, India
Phone: +91 40 4047 3535

Established in 1994, Hetero Healthcare Limited is a group company of Hetero which is engaged in the marketing and distribution of medicines in the Indian market. The company has a strong presence in India with 11 specialized marketing divisions and has been a market leader in ARV, Oncology, anti-flu anti-bacterial. With the team of 3200+ field force, Hetero Healthcare caters to medical practitioners in over 400 territories across India.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Favivir by Hetero Healthcare for Mild to Moderate Covid-19 is Available Now here

News-ID: 2099602 • Views:

More Releases from Hetero Healthcare Limited

Hetero Healthcare set to supply Covid-19 drug Remdesivir under brand name COVIFO …
Hetero’s group company ‘Hetero Healthcare Limited’ is all set to supply 20,000 vials of Covifor (Remdesivir)across the country. Following the approval of ‘COVIFOR’, the generic of Remdesivir by DCGI, Hetero Healthcare Limited, a group company of Heterois set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which, will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of